ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALXO ALX Oncology Holdings

盘后交易 05-02 16:46:36 EDT

16.62

-0.32

-1.89%

盘后16.29

-0.33-1.99%

16:41 EDT

最高17.39	最低16.53	成交量49.44万
今开17.39	昨收16.94	日振幅5.08%
总市值8.39亿	流通市值3.74亿	总股本5,050万
成交额834.82万	换手率2.20%	流通股本2,248万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":16.62,"timestamp":1714680000000,"preClose":16.94,"halted":0,"volume":494357,"hourTrading":{"tag":"盘后","latestPrice":16.29,"preClose":16.62,"latestTime":"16:41 EDT","volume":16449,"amount":273384.18939,"timestamp":1714682474928},"delay":0,"floatShares":22478229,"shares":50498816,"eps":-3.740715,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.32,"latestTime":"05-02 16:46:36 EDT","open":17.39,"high":17.39,"low":16.53,"amount":8348232.859921001,"amplitude":0.050767,"askPrice":16.94,"askSize":71,"bidPrice":16.3,"bidSize":92,"shortable":3,"etf":0,"ttmEps":-3.740715,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714694400000},"adr":0,"listingDate":1594958400000,"adjPreClose":16.94,"postHourTrading":{"tag":"盘后","latestPrice":16.29,"preClose":16.62,"latestTime":"16:41 EDT","volume":16449,"amount":273384.18939,"timestamp":1714682474928},"volumeRatio":0.995416},"requestUrl":"/m/hq/s/ALXO/tweets","defaultTab":"tweets","newsList":[{"id":"2429713679","title":"Alx Oncology Holdings Inc.盘中异动 快速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429713679","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429713679?lang=zh_cn&edition=full","pubTime":"2024-04-23 01:02","pubTimestamp":1713805320,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日01时02分，Alx Oncology Holdings Inc.股票出现波动，股价大幅下挫5.13%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.58%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102007a549de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404230102007a549de0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427187636","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速拉升5.20%报13.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427187636","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427187636?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:43","pubTimestamp":1713278621,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日22时43分，Alx Oncology Holdings Inc.股票出现波动，股价大幅上涨5.20%。截至发稿，该股报13.56美元/股，成交量9.1638万股，换手率0.18%，振幅5.35%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622434187e80ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041622434187e80ff7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427000611","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速跳水5.06%报12.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427000611","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427000611?lang=zh_cn&edition=full","pubTime":"2024-04-15 23:20","pubTimestamp":1713194413,"startTime":"0","endTime":"0","summary":"北京时间2024年04月15日23时20分，Alx Oncology Holdings Inc.股票出现波动，股价大幅下跌5.06%。截至发稿，该股报12.37美元/股，成交量5.015万股，换手率0.10%，振幅5.45%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041523201387e807df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041523201387e807df&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427092753","title":"Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.23%报12.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427092753","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427092753?lang=zh_cn&edition=full","pubTime":"2024-04-13 01:35","pubTimestamp":1712943345,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日01时35分，Alx Oncology Holdings Inc.股票出现波动，股价快速下跌5.23%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为1.46%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。该信息摘要如下：HC Wainwright & Co.：重申ALX Oncology Holdings评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130135457a527b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130135457a527b3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426262986","title":"Alx Oncology Holdings Inc.盘中异动 临近午盘股价大涨5.19%报12.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426262986","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426262986?lang=zh_cn&edition=full","pubTime":"2024-04-11 23:59","pubTimestamp":1712851181,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日23时59分，Alx Oncology Holdings Inc.股票出现异动，股价急速拉升5.19%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。该信息摘要如下：HC Wainwright & Co.：重申ALX Oncology Holdings评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411235941791ff4db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411235941791ff4db&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426612411","title":"HC Wainwright & Co.：重申ALX Oncology Holdings(ALXO.US)评级，由买入调整至买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426612411","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426612411?lang=zh_cn&edition=full","pubTime":"2024-04-10 23:25","pubTimestamp":1712762725,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申ALX Oncology Holdings(ALXO.US)评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102325288761f58d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404102325288761f58d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421559841","title":"Alx Oncology Holdings Inc.盘中异动 快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421559841","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421559841?lang=zh_cn&edition=full","pubTime":"2024-03-23 00:19","pubTimestamp":1711124376,"startTime":"0","endTime":"0","summary":"北京时间2024年03月23日00时19分，Alx Oncology Holdings Inc.股票出现异动，股价快速下挫5.04%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323001936861e07be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240323001936861e07be&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421771381","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.10%报12.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421771381","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421771381?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:05","pubTimestamp":1710957946,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时05分，Alx Oncology Holdings Inc.股票出现异动，股价快速上涨5.10%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至02时05分，《ALX Oncology董事增持4,400股普通股股份，价值约4.98万美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321020546861dfd01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240321020546861dfd01&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420220773","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.02%报11.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420220773","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420220773?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:57","pubTimestamp":1710856679,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时57分，Alx Oncology Holdings Inc.股票出现波动，股价大幅拉升5.02%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。消息层面，截至21时57分，《ALX Oncology董事增持4,400股普通股股份，价值约4.98万美元》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921575987e7a142&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031921575987e7a142&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419600827","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419600827","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419600827?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:46","pubTimestamp":1710424000,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时46分，Alx Oncology Holdings Inc.股票出现异动，股价大幅下跌5.04%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214641791a7c55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314214641791a7c55&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419633514","title":"Alx Oncology Holdings Inc.盘中异动 早盘急速下挫5.01%报11.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419633514","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419633514?lang=zh_cn&edition=full","pubTime":"2024-03-13 22:35","pubTimestamp":1710340538,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日22时35分，Alx Oncology Holdings Inc.股票出现异动，股价急速下挫5.01%。截至发稿，该股报11.75美元/股，成交量6.399万股，换手率0.13%，振幅4.92%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132235397a4c573a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132235397a4c573a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418559962","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速跳水5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418559962","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418559962?lang=zh_cn&edition=full","pubTime":"2024-03-12 23:06","pubTimestamp":1710255973,"startTime":"0","endTime":"0","summary":"北京时间2024年03月12日23时06分，Alx Oncology Holdings Inc.股票出现波动，股价大幅跳水5.13%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122306147919bffa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403122306147919bffa&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417508050","title":"Alx Oncology Holdings Inc.股价重挫16.19% 市值跌1.11亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417508050","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417508050?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:31","pubTimestamp":1709908300,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时31分，Alx Oncology Holdings Inc.股票出现异动，股价大幅跳水16.19%。截至发稿，该股报13.61美元/股，成交量4.1839万股，换手率0.08%，振幅6.80%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231408b189c85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082231408b189c85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417728345","title":"ALX 肿瘤控股公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2417728345","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2417728345?lang=zh_cn&edition=full","pubTime":"2024-03-08 08:00","pubTimestamp":1709856055,"startTime":"0","endTime":"0","summary":"   * ALX Oncology Holdings Inc   报告，截至12月底的季度调整后每股亏损93美分，低于去年同期的每股-75美分。七位分析师对该季度的平均预期是每股亏损 84 美分。华尔街预期为每股亏损 1.06 美元至-63 美分。* ALX Oncology Holdings Inc 公布的季度每股收益为亏损 93 美分。* 该公司当季亏损 4547 万美元。* ALX Oncology Holdings Inc 本季度股价下跌了 0.8%。华尔街对 ALX Oncology Holdings Inc 的 12 个月目标价中位数为 17.75 美元。本摘要由 LSEG 3 月 8 日上午 12:00  的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2417792519","title":"Alx Oncology Holdings Inc.盘中异动 临近午盘股价大涨5.21%报15.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417792519","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417792519?lang=zh_cn&edition=full","pubTime":"2024-03-08 00:59","pubTimestamp":1709830796,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日00时59分，Alx Oncology Holdings Inc.股票出现波动，股价快速上涨5.21%。截至发稿，该股报15.54美元/股，成交量5.4544万股，换手率0.11%，振幅5.48%。Alx Oncology Holdings Inc.股票所在的生物技术行业中，整体涨幅为2.75%。Alx Oncology Holdings Inc.公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080059577a4a858e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403080059577a4a858e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415320802","title":"Alx Oncology Hldgs Inc盘中异动 早盘股价大跌6.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415320802","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2415320802?lang=zh_cn&edition=full","pubTime":"2024-02-28 22:30","pubTimestamp":1709130629,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日22时30分，Alx Oncology Hldgs Inc股票出现异动，股价急速跳水6.15%。Alx Oncology Hldgs Inc股票所在的生物技术行业中，整体涨幅为0.37%。Alx Oncology Hldgs Inc公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822303079158bba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022822303079158bba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414333328","title":"Alx Oncology Hldgs Inc盘中异动 股价大涨6.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414333328","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414333328?lang=zh_cn&edition=full","pubTime":"2024-02-26 22:37","pubTimestamp":1708958260,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日22时37分，Alx Oncology Hldgs Inc股票出现波动，股价快速拉升6.24%。Alx Oncology Hldgs Inc股票所在的生物技术行业中，整体涨幅为0.16%。Alx Oncology Hldgs Inc公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262237407914b285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262237407914b285&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413464420","title":"Alx Oncology Hldgs Inc盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413464420","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413464420?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:37","pubTimestamp":1708529856,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日23时37分，Alx Oncology Hldgs Inc股票出现波动，股价急速跳水5.31%。截至发稿，该股报15.39美元/股，成交量2.2031万股，换手率0.04%，振幅4.86%。Alx Oncology Hldgs Inc股票所在的生物技术行业中，整体跌幅为0.23%。Alx Oncology Hldgs Inc公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221233736791325bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240221233736791325bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411549046","title":"Alx Oncology Hldgs Inc盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2411549046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411549046?lang=zh_cn&edition=full","pubTime":"2024-02-15 22:33","pubTimestamp":1708007608,"startTime":"0","endTime":"0","summary":"北京时间2024年02月15日22时33分，Alx Oncology Hldgs Inc股票出现异动，股价快速上涨5.56%。Alx Oncology Hldgs Inc股票所在的生物技术行业中，整体涨幅为0.36%。Alx Oncology Hldgs Inc公司简介：ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司，专注于帮助患者对抗癌症，开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道，以CD47阻断剂evorpacept为首，目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402152233297a43d282&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402152233297a43d282&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alxoncology.com","stockEarnings":[{"period":"1week","weight":0.0444},{"period":"1month","weight":0.5372},{"period":"3month","weight":0.1293},{"period":"6month","weight":1.0361},{"period":"1year","weight":1.9283},{"period":"ytd","weight":0.1377}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段免疫肿瘤学公司，致力于通过开发阻断CD47检查点通路并连接先天性和适应性免疫系统的疗法，帮助患者抗癌。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.135783},{"month":2,"riseRate":0.75,"avgChangeRate":-0.031126},{"month":3,"riseRate":0,"avgChangeRate":-0.176518},{"month":4,"riseRate":0.5,"avgChangeRate":0.111643},{"month":5,"riseRate":0.25,"avgChangeRate":-0.09475},{"month":6,"riseRate":0.666667,"avgChangeRate":0.049152},{"month":7,"riseRate":0.666667,"avgChangeRate":0.027026},{"month":8,"riseRate":0.75,"avgChangeRate":0.118061},{"month":9,"riseRate":0.5,"avgChangeRate":-0.037177},{"month":10,"riseRate":0.75,"avgChangeRate":0.143545},{"month":11,"riseRate":0.5,"avgChangeRate":0.13105},{"month":12,"riseRate":0.75,"avgChangeRate":0.175818}],"exchange":"NASDAQ","name":"ALX Oncology Holdings","nameEN":"ALX Oncology Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALX Oncology Holdings,ALXO,ALX Oncology Holdings股票,ALX Oncology Holdings股票老虎,ALX Oncology Holdings股票老虎国际,ALX Oncology Holdings行情,ALX Oncology Holdings股票行情,ALX Oncology Holdings股价,ALX Oncology Holdings股市,ALX Oncology Holdings股票价格,ALX Oncology Holdings股票交易,ALX Oncology Holdings股票购买,ALX Oncology Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}